Clinical Trials in Shenyang, China
Locations / Shenyang, China
Delta Trials records 2,361 clinical trials conducted in Shenyang, China, making it a notable site of clinical research activity. These trials across 1,647 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 94 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Shenyang has changed over time.
2361
Total Trials
1647
Conditions
94
Terminated since 2020
Browse by condition (1647 total)
- Non-small cell lung cancer 82 trialsAll Non-small cell lung cancer trials
- Breast cancer 76 trialsAll Breast cancer trials
- Asthma 43 trialsAll Asthma trials
- Gastric cancer 38 trialsAll Gastric cancer trials
- Advanced solid tumor 32 trialsAll Advanced solid tumor trials
- Diabetes mellitus, type 2 31 trialsAll Diabetes mellitus, type 2 trials
- Coronary artery disease 31 trialsAll Coronary artery disease trials
- Ischemic stroke 28 trialsAll Ischemic stroke trials
- Type 2 diabetes mellitus 24 trialsAll Type 2 diabetes mellitus trials
- Stroke 24 trialsAll Stroke trials
- Hepatocellular carcinoma 22 trialsAll Hepatocellular carcinoma trials
- Multiple myeloma 22 trialsAll Multiple myeloma trials
- Atopic dermatitis 22 trialsAll Atopic dermatitis trials
- Colorectal cancer 21 trialsAll Colorectal cancer trials
- Heart failure 21 trialsAll Heart failure trials
- Solid tumor 19 trialsAll Solid tumor trials
- Advanced solid tumors 19 trialsAll Advanced solid tumors trials
- Pulmonary disease, chronic obstructive 16 trialsAll Pulmonary disease, chronic obstructive trials
- Acute coronary syndrome 16 trialsAll Acute coronary syndrome trials
- Acute ischemic stroke 16 trialsAll Acute ischemic stroke trials